Nanomaterials for Chronic Kidney Disease Detection

Applied Sciences

Solmaz Maleki Dizaj¹  Aygun Nasibova²  Rovshan Khalilov²  Soodabeh Davaran³  Mahbuba Valiyeva⁴  Sevil Mehraliyeva⁴  Shakar Mammadova⁵  Elham Ahmadian⁶  Mohammadreza Ardalan⁶  Aziz Eftekhari⁷  Ebrahim Mostafavi⁸ 

[1] Dental and Periodontal Research Center, Tabriz University of Medical Sciences, Tabriz 5166614756, Iran;Department of Biophysics and Biochemistry, Baku State University, Baku 1148, Azerbaijan;Department of Medicinal Chemistry, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz 5166614756, Iran;Department of Pharmaceutical Technology and Management, Azerbaijan Medical University, Baku 1022, Azerbaijan;Department of Physical Geography, Baku State University, Baku 1148, Azerbaijan;Kidney Research Center, Tabriz University of Medical Sciences, Tabriz 5166614756, Iran;Pharmacology and Toxicology Department, Maragheh University of Medical Sciences, Maragheh 7815155158, Iran;Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA;

关键词: nanoparticles;    kidney disease;    chronic kidney disease;    targeting;    review;   

DOI  :  10.3390/app11209656

来源: DOAJ

【 摘 要 】

Chronic kidney disease (CKD) is a dilapidating problem that causes great global burden since the current therapeutic options are mostly ineffective. Early diagnosis and efficient treatment are essential to prevent the progression of CKD. Nanoparticles as technological drivers of innovation have emerged in biomedical studies for different theranostic applications. Several nanoparticles have been developed, which can be labeled with targeting moieties for both drug delivery and/or imaging systems and are investigated to detect different pathological conditions. The focus of this review is to demonstrate the current research and clinical applications for nanoparticles in the diagnosis of CKD and other renal diseases that will probably result in CKD.

【 授权许可】

Unknown